Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Janssen Korea Ltd
Woman and Man Max 99 years
Janssen Korea Ltd
Update Il y a 4 ans
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate the safety and efficacy of Osmotic Release Oral System (OROS) methylphenidate in participants with Attention Deficit Hyperactivity Disorder (ADHD).
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Janssen Korea Ltd
Update Il y a 4 ans
A study to evaulate the most favourable treatment dose in childrens and adolescents with Attention-Deficit Hyperactivity Disorder
The purpose of this study is to evaluate the optimal dosages of Osmotic Release Oral System (OROS) methylphenidate in participants with Attention Deficit Hyperactivity Disorder (ADHD).
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Janssen Korea Ltd
Update Il y a 4 ans
An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate the efficacy, tolerability and effects of Osmotic Release Oral System (OROS) methylphenidate hydrochloride (HCl) on learning skill changes in Korean participan...
Country
None
organs
None
Specialty
None
More information